Rad Tech Minutes 2025-11-10-14: Difference between revisions

From IHE Wiki
Jump to navigation Jump to search
Kevino (talk | contribs)
 
(12 intermediate revisions by 3 users not shown)
Line 21: Line 21:
:*Ana Kostadinovska | Philips*
:*Ana Kostadinovska | Philips*
:*Teri Sippel | Johns Hopkins
:*Teri Sippel | Johns Hopkins
:*Khaled Younis | MedAiConsult LLC*
:*Rob Ferre*
:*Allan B.*


''Non-voting''
''Non-voting''
Line 73: Line 76:
:*S3: 1:30pm-3:30pm: Manifest-based Access to DICOM Objects (MADO) [5.5 hr]  
:*S3: 1:30pm-3:30pm: Manifest-based Access to DICOM Objects (MADO) [5.5 hr]  
:*S4: 3:45pm-5.00pm: Maintenance [2.5 hr]
:*S4: 3:45pm-5.00pm: Maintenance [2.5 hr]
:** CP-RAD-549-refactor RAD-50 Store Instances for reuse (Lynn) (originated w/ AIRA)Completed and approved for ballot
:** CP-RAD-554-refactor RAD-14 Query images for reuse (Lynn) (originated w/ AIRA) - Completed and approved for ballot
:** Group Dinner at Blanco Cocina @ 6:00pm
:** Group Dinner at Blanco Cocina @ 6:00pm


Line 81: Line 86:
:**[https://www.ihe.net/about_ihe/member_organizations/ IHE International Member Organizations]
:**[https://www.ihe.net/about_ihe/member_organizations/ IHE International Member Organizations]
:**IHE Patent Disclosure
:**IHE Patent Disclosure
:*S1: 9:00am-11:00am: Imaging Diagnostic Report (IDR)[7.5 hr]
:*S1: 9:00am-11:00am: Imaging Diagnostic Report (IDR)[6.5 hr]
:*S2: 11:15am-12:45pm: Manifist-based Access to DICOM Objects (MADO) - Phase 2 [7 hr]   
:*S2: 11:15am-12:45pm: Manifest-based Access to DICOM Objects (MADO) - Phase 2 [7 hr]   
:*S3: 1:30pm-3:30pm: Imaging Diagnostic Report (IDR) - Phase 2 [9.5 hr]  
:*S3: 1:30pm-3:30pm: Imaging Diagnostic Report (IDR) - Phase 2 [8.5 hr]  
:*S5: 3:45pm-5:00pm: Maintenance [3.75 h]
:*S5: 3:45pm-5:00pm: Maintenance [3.75 h]
:** CP-RAD-440 EBIW – RAD-130 return and matching keys (Kinson) reviewed - agreed to cancel CP  as no action is needed (addressed with POCUS extension of EBIW). Cancellation rationale provided.
:** CP-RAD-563 Add Audit Trail triggers for POCUS (Steven) - reviewed and approved for letter ballot


=='''Thursday, November 13, 2025'''==
=='''Thursday, November 13, 2025'''==
:*A1:  8:45am-9:00am  Administrative Time
:*A1:  8:45am-9:00am  Administrative Time
:*S1: 9:00am-10:30am: Manifist-based Access to DICOM Objects (MADO) [7.5 hr]
:*S1: 9:00am-10:30am: Manifest-based Access to DICOM Objects (MADO) [8.5 hr]
:*S2: 10:45am-12:15pm: Manifist-based Access to DICOM Objects (MADO)[9 hr]  
:*S2: 10:45am-12:15pm: Manifest-based Access to DICOM Objects (MADO) [10 hr]  
:*S3: 1:00pm-3:00pm: Imaging Diagnostic Report (IDR) - Phase 2 [11.5 hr]
:*S3: 1:00pm-3:00pm: Imaging Diagnostic Report (IDR) - Phase 2 [10.5 hr]
:*S4: 3:15-5:00pm  Maintenance [5.5 hr]
:*S4: 3:15-5:00pm  Maintenance [5.5 hr]
:** CP-RAD-443 Clarify Series Date/Time vs Performed Procedure Step Start Date/Time (Andrei) reviewed - agreed to cancel CP  as no action is needed. Cancellation rationale provided. Andrei will email Gunter with explanation.
:** CP-RAD-474 Extensions to RAD-106 for IMR (Kinson) - reviewed - additional work required
:** CP-RAD-476 - Code Mapping Whitepaper - out-of-date-statements (Kinson) - reviewed and approved for ballot
:** CP-RAD-510 - Correct Resource Name in IMR Bundle Example (Kinson) - reviewed and approved for ballot (note change in the title for clarity)
:** CP-RAD-539-01 - IOCM Issue 7 (Kinson) - reviewed and approved for ballot
:** CP-RAD-556-00-add-RESTful-to-RAD-66 (Lynn).  Reviewed - approved for ballot pending final changes by Lynn (with approveal by e-mail).


=='''Friday, November 14, 2025'''==
=='''Friday, November 14, 2025'''==
:*A1:  8:45am-9:00am  Administrative Time
:*A1:  8:45am-9:00am  Administrative Time
:*S1: 9:00am-10:30am Manifist-based Access to DICOM Objects (MADO) - including [[MADO_Checkpoint_Assessment]] [10.5 hr]
:*S1: 8:45am-9:45am Checkpoint - Manifest-based Access to DICOM Objects (MADO) [https://docs.google.com/document/d/1xAY_VQtZY4MyQDTLgwk8JgKH5a5uRT6P/edit?usp=share_link&ouid=111306937438382146052&rtpof=true&sd=true]
:*S2: 10:45am-12:45pm Imaging Diagnostic Report (IDR) - Phase 2 - including [[IDR-II_Checkpoint_Assessment]] [13.5 hr]
:*S1: 9:45am-10:45am Manifest-based Access to DICOM Objects (MADO) [11 hr]
:*S2: 11:00am-12:00pm Checkpoint - Imaging Diagnostic Report (IDR) - Phase 2
Profile Name: IDR Phase II
* Describe gaps in Use Case coverage
:* Some expansions of both use case during discussion, but look pretty good.
* Review ALL "uncertainty points" in the evaluation. Is there a resolution plan for each?
:* Yes. Noted as (UP) in the review document. Covered each.
* Do the effort points in the evaluation still seem right?
:* Mostly. Given the broad scope of finding encoding, still possibility for tough issues to emerge.
* Did the Breakdown of Tasks accurately reflect the work? What extra tasks arose?
:* Need to rebuild the EU-IHE Comparison Spreadsheet details.
 
* Describe unresolved technical issues/tasks
:* Lots of “examples->coding” work to do before PC-Prep
 
* Describe potential practical issues
:* Assuming that the patterns of grouping individual observations will scale up successfully for an entire complex findings section
 
* Review the open issue list. Does it feel complete
:* GAP – do not have a formal Open Issue list yet. Will have it for PC-Prep
 
* Which open issues feel most risky; what other risks exist?
:* General wide breadth of scope.  It will get exercised to the extent of the examples, but tricky details will lurk. Probably just depends on iterative evolution.
:* How do we characterize the scope? Final Report. All modalities.
:* E.g. one well-defined example per major subspecialty (neuro CT/MR, Chest CT, Chest XR, CAP CT, MSK Trauma, MG BIRADS, Cardiac UL, Liver UL?, Onc PET, exclude Interventional (XA), )
:* Note that the specs are general, the examples are specific
 
* How is the work fitting in the allocated bandwidth? (Time to spare? Just right? Things were left undone?)
:* Mostly right.
 
* How does the scope feel? (Room to expand? Just right? Pretty ambitious?)
:* Mostly right. A bit ambitious due to the nature of findings being a large scope, but this will be a good start.
 
* If you had to reduce scope, what would you drop?
:* Transaction definitions; fewer examples
 
* Have the promised resources manifested?
:* Mostly. Participation before the meeting from some CDE folks and they have committed to reviewing. Had remote participation from HL7 EU
 
* What tasks would benefit from additional expertise?
:* will be leaning on Tarik and the CDE folks once there is concrete content to review
:* would be nice to have Report Creators engaged
 
* What vendors are engaged for each actor? Record how many.
:* Indirect Nuance participation through Tarik but need more direct engagement on all fronts. TODO
:* Recruit at Radiology Reimagined: RadAI, Rad Pair (Jason), Hoppr, Jacobian (David),
::* Point people to the Phase I IDR and encourage participation in Phase II
::* At least target during PC - get email addresses
 
* Was the profile where it needed to be at the start of the Kickoff meeting (See "Kickoff Meeting" above), if not what was the gap
:* Good list of topics and materials for discussion;
:* Would have been nice to have a draft Profile document, but that will be here for PC Prep
 
* Was the profile where it needed to be at the end of the Kickoff meeting, if not what was the gap
:* Uncertainty topics mostly resolved.
:* Good input on concepts in general
:* Would have been nice to have a draft document
:* There’s going to be a lot of example work to do
 
* How many tcons would you like between now and the PC Prep Meeting?
:* One Clinical Consult (Jan 2nd week?), One Tech Cmte (Also Jan 2nd week?)
:* Kevin will reach out for CC call; cc Valerie (CDE Cmte) and Jamie (IHE)

Latest revision as of 13:46, 20 November 2025

Participants

  • Wim Corbijn van Willenswaard | Philips | RadTech Co-chair
  • Andrei Leontiev | Viasge Imaging | RadTech Co-chair
  • Mike Bohl | Dose Registry | RadPlan Co-chair
  • Kevin O'Donnall | Canon Medical Research | Domain Representative to IHE International Board
  • Antje Schroeder | Siemens Healthineers
  • Steve Nichols | GE
  • Charles Parisot | InteropEhealth*
  • David Kwan | Insygnia Consulting*
  • Harald Zachmann | Merge/Merative*
  • Bas van den Heuvel | Philips*
  • Kinson Ho | Optum*
  • Paul Shum | Optum*
  • Jonathan Whitby | Canon Medical Research*
  • Nick Hermans | UZ Leuven*
  • Rick Busbridge | Nictiz*
  • Yasunari "Salt" Shiokawa | JAHIS*
  • Griffin Fairchok | Epic*
  • Ignacio Jauregu | Philips*
  • Ana Kostadinovska | Philips*
  • Teri Sippel | Johns Hopkins
  • Khaled Younis | MedAiConsult LLC*
  • Rob Ferre*
  • Allan B.*

Non-voting

  • Jason Nagels | IHE Radiology Technical Project Manager
  • Mohannad Hussain | IHE Radiology Technical Project Manager*
  • Jamie Dulkowski | RSNA | Secretary
  • Chris Carr | RSNA | Secretary
  • Lynn Felhofer | Special Guest

(*) = Remote attendance



All times are U.S. Central Time.

Monday, November 10, 2025

  • Would like to keep this in CARD, however, CARD domain is dormant
  • Progress is slower than expected
  • No CPs filed, not intending to restart CP processing
  • Profile is fairly minimal, adding a use case
  • RAD is off the hook for now
  • If/when this work gets restarted, send notification to IHE Radiology communication channels
  • Action: Jamie will investigate if CARD google groups are active
  • Interest expressed from Visage and Philips to help move this work along
  • Newly submitted CP - CP-RAD-562 Move DICOM Usage Conventions (assigned to Lynn, to be re-assigned)
  • Prepare CPs for Ballot 2025B to be shared prior to February F2F meeting

Tuesday, November 11, 2025

  • A1: 8:45am-9:00am Administrative Time
  • S1: 9:00am-10:00am: Imaging Diagnostic Report (IDR) - Phase 2 [4.5 hr]
  • S1a: Maintenance
    • Discussion on the EU regulation on labeling AI-generated content - Antje to propose a CP for AIR and AIRA profiles (both in TI) what attributes (such as SyntheticData should be recommended for use of appropriate labeling. Goal to flash out the use case and propose a CP to DICOM if needed.
    • Newly submitted CP - CP-RAD-563 Add Audit Trail triggers for POCUS (assigned to Steve)
  • S2: 11:15am-12:45pm: Manifest-based Access to DICOM Objects (MADO) [3.5 hr]
  • S3: 1:30pm-3:30pm: Manifest-based Access to DICOM Objects (MADO) [5.5 hr]
  • S4: 3:45pm-5.00pm: Maintenance [2.5 hr]
    • CP-RAD-549-refactor RAD-50 Store Instances for reuse (Lynn) (originated w/ AIRA)Completed and approved for ballot
    • CP-RAD-554-refactor RAD-14 Query images for reuse (Lynn) (originated w/ AIRA) - Completed and approved for ballot
    • Group Dinner at Blanco Cocina @ 6:00pm

Wednesday, November 12, 2025

  • A1: 8:45am-9:00am Administrative Time
  • S1: 9:00am-11:00am: Imaging Diagnostic Report (IDR)[6.5 hr]
  • S2: 11:15am-12:45pm: Manifest-based Access to DICOM Objects (MADO) - Phase 2 [7 hr]
  • S3: 1:30pm-3:30pm: Imaging Diagnostic Report (IDR) - Phase 2 [8.5 hr]
  • S5: 3:45pm-5:00pm: Maintenance [3.75 h]
    • CP-RAD-440 EBIW – RAD-130 return and matching keys (Kinson) reviewed - agreed to cancel CP as no action is needed (addressed with POCUS extension of EBIW). Cancellation rationale provided.
    • CP-RAD-563 Add Audit Trail triggers for POCUS (Steven) - reviewed and approved for letter ballot

Thursday, November 13, 2025

  • A1: 8:45am-9:00am Administrative Time
  • S1: 9:00am-10:30am: Manifest-based Access to DICOM Objects (MADO) [8.5 hr]
  • S2: 10:45am-12:15pm: Manifest-based Access to DICOM Objects (MADO) [10 hr]
  • S3: 1:00pm-3:00pm: Imaging Diagnostic Report (IDR) - Phase 2 [10.5 hr]
  • S4: 3:15-5:00pm Maintenance [5.5 hr]
    • CP-RAD-443 Clarify Series Date/Time vs Performed Procedure Step Start Date/Time (Andrei) reviewed - agreed to cancel CP as no action is needed. Cancellation rationale provided. Andrei will email Gunter with explanation.
    • CP-RAD-474 Extensions to RAD-106 for IMR (Kinson) - reviewed - additional work required
    • CP-RAD-476 - Code Mapping Whitepaper - out-of-date-statements (Kinson) - reviewed and approved for ballot
    • CP-RAD-510 - Correct Resource Name in IMR Bundle Example (Kinson) - reviewed and approved for ballot (note change in the title for clarity)
    • CP-RAD-539-01 - IOCM Issue 7 (Kinson) - reviewed and approved for ballot
    • CP-RAD-556-00-add-RESTful-to-RAD-66 (Lynn). Reviewed - approved for ballot pending final changes by Lynn (with approveal by e-mail).

Friday, November 14, 2025

  • A1: 8:45am-9:00am Administrative Time
  • S1: 8:45am-9:45am Checkpoint - Manifest-based Access to DICOM Objects (MADO) [1]
  • S1: 9:45am-10:45am Manifest-based Access to DICOM Objects (MADO) [11 hr]
  • S2: 11:00am-12:00pm Checkpoint - Imaging Diagnostic Report (IDR) - Phase 2

Profile Name: IDR Phase II

  • Describe gaps in Use Case coverage
  • Some expansions of both use case during discussion, but look pretty good.
  • Review ALL "uncertainty points" in the evaluation. Is there a resolution plan for each?
  • Yes. Noted as (UP) in the review document. Covered each.
  • Do the effort points in the evaluation still seem right?
  • Mostly. Given the broad scope of finding encoding, still possibility for tough issues to emerge.
  • Did the Breakdown of Tasks accurately reflect the work? What extra tasks arose?
  • Need to rebuild the EU-IHE Comparison Spreadsheet details.
  • Describe unresolved technical issues/tasks
  • Lots of “examples->coding” work to do before PC-Prep
  • Describe potential practical issues
  • Assuming that the patterns of grouping individual observations will scale up successfully for an entire complex findings section
  • Review the open issue list. Does it feel complete
  • GAP – do not have a formal Open Issue list yet. Will have it for PC-Prep
  • Which open issues feel most risky; what other risks exist?
  • General wide breadth of scope. It will get exercised to the extent of the examples, but tricky details will lurk. Probably just depends on iterative evolution.
  • How do we characterize the scope? Final Report. All modalities.
  • E.g. one well-defined example per major subspecialty (neuro CT/MR, Chest CT, Chest XR, CAP CT, MSK Trauma, MG BIRADS, Cardiac UL, Liver UL?, Onc PET, exclude Interventional (XA), )
  • Note that the specs are general, the examples are specific
  • How is the work fitting in the allocated bandwidth? (Time to spare? Just right? Things were left undone?)
  • Mostly right.
  • How does the scope feel? (Room to expand? Just right? Pretty ambitious?)
  • Mostly right. A bit ambitious due to the nature of findings being a large scope, but this will be a good start.
  • If you had to reduce scope, what would you drop?
  • Transaction definitions; fewer examples
  • Have the promised resources manifested?
  • Mostly. Participation before the meeting from some CDE folks and they have committed to reviewing. Had remote participation from HL7 EU
  • What tasks would benefit from additional expertise?
  • will be leaning on Tarik and the CDE folks once there is concrete content to review
  • would be nice to have Report Creators engaged
  • What vendors are engaged for each actor? Record how many.
  • Indirect Nuance participation through Tarik but need more direct engagement on all fronts. TODO
  • Recruit at Radiology Reimagined: RadAI, Rad Pair (Jason), Hoppr, Jacobian (David),
  • Point people to the Phase I IDR and encourage participation in Phase II
  • At least target during PC - get email addresses
  • Was the profile where it needed to be at the start of the Kickoff meeting (See "Kickoff Meeting" above), if not what was the gap
  • Good list of topics and materials for discussion;
  • Would have been nice to have a draft Profile document, but that will be here for PC Prep
  • Was the profile where it needed to be at the end of the Kickoff meeting, if not what was the gap
  • Uncertainty topics mostly resolved.
  • Good input on concepts in general
  • Would have been nice to have a draft document
  • There’s going to be a lot of example work to do
  • How many tcons would you like between now and the PC Prep Meeting?
  • One Clinical Consult (Jan 2nd week?), One Tech Cmte (Also Jan 2nd week?)
  • Kevin will reach out for CC call; cc Valerie (CDE Cmte) and Jamie (IHE)